| |
| |
|
| Insider
Information: |
Beer Marc D |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
128,631 |
|
|
Indirect Shares
|
246,462 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
375,093 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 60.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aegerion Pharmaceuticals, Inc. |
AEGR |
Chief Executive Office... |
2014-08-28 |
78,631 |
2014-08-28 |
246,462 |
Premium* |
|
|
Minerva Neurosciences, Inc. |
NERV |
Director |
2017-03-20 |
50,000 |
2017-03-17 |
0 |
Premium* |
|
|
Biote Ord Shs Class A |
BTMD |
Director |
2023-01-09 |
0 |
2022-05-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2014-05-20 |
4 |
B |
$30.53 |
$305,300 |
D/D |
10,000 |
43,000 |
2.81 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2014-05-21 |
4 |
OE |
$1.54 |
$9,856 |
D/D |
6,400 |
49,400 |
0 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2014-05-27 |
4 |
B |
$31.59 |
$315,900 |
D/D |
10,000 |
59,400 |
2.81 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2014-06-03 |
4 |
B |
$30.12 |
$301,200 |
D/D |
10,000 |
69,400 |
2.81 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2014-07-31 |
4 |
B |
$33.44 |
$336,539 |
D/D |
10,000 |
79,400 |
2.81 |
- |
|
| AEGR |
Aegerion Pharmaceuticals,... |
Chief Executive Officer |
• • – |
2014-08-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
769 |
78,631 |
0 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2017-03-17 |
4 |
B |
$8.34 |
$208,500 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
| NERV |
Minerva Neurosciences, In... |
Director |
– • – |
2017-03-20 |
4 |
B |
$7.89 |
$197,250 |
D/D |
25,000 |
50,000 |
2.39 |
- |
|
| BTMD |
Biote Ord Shs Class A |
Director |
– • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,178,089 |
3,178,089 |
0 |
- |
|
| BTMD |
Biote Ord Shs Class A |
Director |
– • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
654,387 |
3,832,769 |
0 |
- |
|
| BTMD |
Biote Ord Shs Class A |
Director |
– • – |
2022-05-26 |
4/A |
A |
$0.00 |
$0 |
D/D |
654,387 |
3,832,476 |
0 |
- |
|
| BTMD |
Biote Ord Shs Class A |
Director |
– • – |
2023-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
865,384 |
865,384 |
0 |
- |
|
| BTMD |
Biote Ord Shs Class A |
Director |
– • – |
2023-01-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(865,384) |
2,967,092 |
0 |
- |
|
| BTMD |
Biote Ord Shs Class A |
Director |
– • – |
2023-01-09 |
4 |
S |
$3.00 |
$2,596,152 |
D/D |
(865,384) |
0 |
0 |
% |
|
39 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
